Provided by Tiger Trade Technology Pte. Ltd.

Vor Biopharma Inc.

13.46
-0.8001-5.61%
Volume:1.54M
Turnover:20.38M
Market Cap:294.91M
PE:-0.04
High:14.84
Open:14.68
Low:12.41
Close:14.26
52wk High:65.80
52wk Low:2.62
Shares:21.91M
Float Shares:18.97M
Volume Ratio:0.89
T/O Rate:8.14%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-342.6591
EPS(LYR):-34.0333
ROE:-125.43%
ROA:-144.27%
PB:-0.13
PE(LYR):-0.40

Loading ...

Dec 09, 2025

Major Issues Report

Form 8-K - Current report
Nov 13, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 12, 2025

Major Issues Report

Form 8-K - Current report
Nov 03, 2025

Major Issues Report

Form 8-K - Current report
Oct 28, 2025

Major Issues Report

Form 8-K - Current report
Oct 20, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 20, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 16, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 16, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 15, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 15, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 24, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Sep 17, 2025

Major Issues Report

Form 8-K - Current report
Sep 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 02, 2025

Major Issues Report

Form 8-K - Current report
Aug 27, 2025

Major Issues Report

Form 8-K - Current report
Aug 27, 2025

Major Issues Report

Form 8-K - Current report
Aug 12, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]